Skip to main content
. 2025 May 6;47(5):332. doi: 10.3390/cimb47050332
ACC American College of Cardiology
AECs Airway epithelial cells
AHA American Heart Association
AH Arterial hypertension
AHI Apnea-hypopnea index
ALEs Advanced lipoxidation end-products
AMPK AMP-activated protein kinase
AOR Adjusted odds ratio
ARIC Atherosclerosis Risk in Communities Study
BMI Body mass index
BNP B-type natriuretic peptide
BP Blood pressure
CAD Coronary artery disease
CD68 Cluster of differentiation 68
CHF Chronic heart failure
CI Confidence interval
CKD Chronic kidney disease
COPD Chronic obstructive pulmonary disease
CPAP Continuous positive airway pressure
CR Cardiac rehabilitation
CSE Cigarette smoke extract
CVD Cardiovascular disease
CVH Cardiovascular health
DAMP Damage-associated molecular pattern
DCM Diabetic cardiomyopathy
DEX Dexpanthenol
ECHO Echocardiographic
ECM Extracellular matrix
ECV Extracellular volume
EGFR Epidermal growth factor receptor
EMT Epithelial–mesenchymal transition
eNOS Endothelial nitric oxide synthase
EPCs Endothelial progenitor cells
ERC Elastin receptor complex
ESC European Society of Cardiology
FAK kinases Focal adhesion kinase kinases
FBG Fasting blood glucose
FDA Food and Drug Administration
FHS Framingham Heart Study
Gal-3 Galectin-3
GSH-Px Glutathione peroxidase
HbA1C Hemoglobin A1c (glycated hemoglobin)
HCD Hypercaloric diet
HF Heart failure
HFD High-fat diet
HFpEF Heart failure with preserved ejection fraction
HFSA Heart Failure Society of America
HIIT High-intensity interval training
HOMA-IR Homeostasis Model Assessment of Insulin Resistance
HR Hazard ratio
hsCRP High-sensitivity C-reactive protein
HUVECs Human umbilical vein endothelial cells
HVS Hepatic vein serum
ICAM-1 Intercellular adhesion molecule-1
IF Intermittent fasting
IL-1β Interleukin-1 beta
IL-6 Interleukin-6
LCN2 Lipocalin-2
LE8 Life’s Essential 8
LGALS3BP Galectin-3 binding protein
LLPS Liquid–liquid phase separation
LPC Lysophosphatidylcholine
LPS Lipopolysaccharide
LS7 Life’s Simple 7
LV Left ventricle
LVEF Left ventricular ejection fraction
LVH Left ventricular hypertrophy
MCP Modified citrus pectin
MDA Malondialdehyde
MIACT Moderate-intensity aerobic continuous training
MRI Magnetic resonance imaging
MUC1-C/EGFR Mucin 1 C-terminal subunit/Epidermal Growth Factor Receptor
NAC N-acetylcysteine
NADPH oxidase 2 Nicotinamide adenine dinucleotide phosphate oxidase 2
NASH Nonalcoholic steatohepatitis
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells
NO Nitric oxide
NWGR Asparagine-Tryptophan-Glycine-Arginine
NT-proBNP N-terminal pro–B-type natriuretic peptide
OGTT Oral glucose tolerance test
OR Odds ratio
OSA Obstructive sleep apnea
oxLDL Oxidized low-density lipoprotein
PI3K Phosphoinositide 3-kinase
POEM Prospective Investigation of Obesity, Energy and Metabolism
PREVEND Prevention of Renal and Vascular End-stage Disease
PUFA Polyunsaturated fatty acids
PVS Portal vein serum
Ref. References
ROS Reactive oxygen species
RUNX-2 Runt-related transcription factor 2
RV Right ventricular
RVEF Right ventricular ejection fraction
SANRA Scale for the Assessment of Narrative Review Articles
SAT Subcutaneous adipose tissue
SBP Systolic blood pressure
SGLT2i Sodium-glucose co-transporter 2 inhibitors
SIRT1 Sirtuin 1
SOD Superoxide dismutase
SNP Sodium nitroprusside
SPPB Short physical performance battery
SR proteins Serine/arginine-rich proteins
STAT3 Signal Transducer and Activator of Transcription 3
STEMI ST-elevation myocardial infarction
SVS Systemic venous serum
T2DM Type 2 diabetes mellitus
TC Total cholesterol
TG Triglycerides
TGF-β Transforming growth factor beta.
TLR4 Toll-like receptor 4
TNF-α Tumor necrosis factor alpha
TOS Total oxidative status
VAT Visceral adipose tissue
VCAM-1 Vascular cell adhesion molecule-1
VCID Vascular cognitive impairment and dementia
VEGFR2 Vascular endothelial growth factor receptor 2
VO2 Oxygen uptake
VSMCs Vascular smooth muscle cells
WAT White adipose tissue
WC Waist circumference
WONDERFUL Weekly ONe-Day WatER-only Fasting InterventionaL trial
WT Wild type
YAP Yes-associated protein
α9nAChR α9 nicotinic acetylcholine receptor
Increase
Decrease